Novartis is hoping for approvals for its new multiple sclerosis therapy siponimod in the US and Europe next year after filing the drug to regulators. Siponimod (BAF312) – which is a follow-up to ...

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self ...

Sanofi’s long and winding path to get its investigational multiple sclerosis drug over the regulatory finish line has taken another turn with the FDA's move to delay its approval decision on the ...